Fate Therapeutics Ownership 2024 | Who Owns Fate Therapeutics Now?
Institutional Ownership
120.84%
Insider Ownership
2.17%
Retail Ownership
-23.02%
Institutional Holders
181.00
Fate Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 13.03% | 2.61% | 13,169,057 | - | - | 43,194,507 | Jun 30, 2024 |
| VANGUARD GROUP INC | 10.45% | 0.00% | 10,569,814 | 658,807 | 6.65% | 34,668,990 | Jun 30, 2024 |
| BLACKROCK INC. | 10.01% | 0.00% | 10,116,106 | 1,016,155 | 11.17% | 33,180,827 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 8.13% | 1.42% | 8,215,910 | - | - | 26,948,185 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 5.51% | 0.55% | 5,572,607 | - | - | 18,278,151 | Jun 30, 2024 |
| STATE STREET CORP | 5.28% | 0.00% | 5,338,689 | -2,697,980 | -33.57% | 17,510,900,000 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 4.79% | 0.26% | 4,839,779 | - | - | 15,874,475 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 4.03% | 0.01% | 4,077,922 | 1,346,956 | 49.32% | 13,375,584 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.52% | 0.19% | 3,555,871 | 1,365,463 | 62.34% | 11,663,257 | Jun 30, 2024 |
| JOHNSON & JOHNSON | 3.34% | 2.77% | 3,379,064 | - | - | 11,083,330 | Jun 30, 2024 |
| MORGAN STANLEY | 3.11% | 0.00% | 3,147,989 | 82,200 | 2.68% | 10,325,404 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 2.96% | 0.13% | 2,997,772 | 1,179,591 | 64.88% | 9,832,692 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 2.55% | 0.02% | 2,574,703 | 26,399 | 1.04% | 8,445,026 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.32% | 0.00% | 2,348,554 | 336,296 | 16.71% | 7,703,257 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.22% | 0.00% | 2,247,383 | 341,400 | 17.91% | 7,372,346 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.11% | 0.00% | 2,130,280 | 1,067,101 | 100.37% | 6,987,215 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.99% | 0.02% | 2,008,862 | 294,738 | 17.19% | 6,587,000 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.98% | 0.49% | 2,000,000 | 1,200,000 | 150.00% | 6,560,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.96% | 0.00% | 1,985,732 | 65,956 | 3.44% | 6,513,201 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.68% | 0.02% | 1,694,217 | -305,605 | -15.28% | 5,557,032 | Jun 30, 2024 |
Fate Therapeutics's largest institutional shareholder is REDMILE GROUP, LLC, holding 13.03% of the company's total share outstanding, currently valued at $43.19M. The top 10 institutional shareholders own together 68.08% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 3.34% | 2.77% | 3,379,064 | - | - | 11,083,330 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 13.03% | 2.61% | 13,169,057 | - | - | 43,194,507 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.49% | 2.06% | 497,360 | -423,116 | -45.97% | 1,631,341 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 8.13% | 1.42% | 8,215,910 | - | - | 26,948,185 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 5.51% | 0.55% | 5,572,607 | - | - | 18,278,151 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.98% | 0.49% | 2,000,000 | 1,200,000 | 150.00% | 6,560,000 | Jun 30, 2024 |
| BRUCE & CO., INC. | 0.30% | 0.32% | 300,000 | 157,000 | 109.79% | 984,000 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 0.52% | 0.27% | 520,800 | - | - | 1,708,224 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.84% | 0.26% | 850,000 | 650,000 | 325.00% | 2,788,000 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 4.79% | 0.26% | 4,839,779 | - | - | 15,874,475 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.86% | 0.25% | 870,000 | - | - | 2,853,600 | Jun 30, 2024 |
| GCM GROSVENOR HOLDINGS, LLC | 0.49% | 0.24% | 495,916 | - | - | 1,626,604 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.69% | 0.23% | 700,000 | - | - | 2,296,000 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.52% | 0.19% | 3,555,871 | 1,365,463 | 62.34% | 11,663,257 | Jun 30, 2024 |
| DOHENY ASSET MANAGEMENT /CA | 0.01% | 0.15% | 7,670 | 7,670 | 100.00% | 263,000 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 0.28% | 0.15% | 286,900 | -29,905 | -9.44% | 941,032 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 2.96% | 0.13% | 2,997,772 | 1,179,591 | 64.88% | 9,832,692 | Jun 30, 2024 |
| PENNANT INVESTORS, LP | 0.14% | 0.13% | 146,100 | - | - | 479,208 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.32% | 0.09% | 324,585 | 324,585 | 100.00% | 1,064,639 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.34% | 0.09% | 1,355,352 | - | - | 4,445,555 | Jun 30, 2024 |
The largest Fate Therapeutics shareholder by % of total assets is JOHNSON & JOHNSON. The company owns 3.38M shares of Fate Therapeutics (FATE), representing 2.77% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.52% | 0.19% | 3,555,871 | 1,365,463 | 62.34% | 11,663,257 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 4.03% | 0.01% | 4,077,922 | 1,346,956 | 49.32% | 13,375,584 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.98% | 0.49% | 2,000,000 | 1,200,000 | 150.00% | 6,560,000 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 2.96% | 0.13% | 2,997,772 | 1,179,591 | 64.88% | 9,832,692 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.11% | 0.00% | 2,130,280 | 1,067,101 | 100.37% | 6,987,215 | Jun 30, 2024 |
| BLACKROCK INC. | 10.01% | 0.00% | 10,116,106 | 1,016,155 | 11.17% | 33,180,827 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.01% | 0.01% | 1,019,987 | 754,987 | 284.90% | 3,345,557 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.02% | 0.09% | 1,032,500 | 672,189 | 186.56% | 3,386,600 | Jun 30, 2024 |
| VANGUARD GROUP INC | 10.45% | 0.00% | 10,569,814 | 658,807 | 6.65% | 34,668,990 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.84% | 0.26% | 850,000 | 650,000 | 325.00% | 2,788,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.54% | 0.00% | 548,544 | 548,544 | 100.00% | 1,799,224 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.44% | 0.00% | 446,668 | 446,668 | 100.00% | 1,465,071 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 0.34% | 0.03% | 345,575 | 345,575 | 100.00% | 1,133,486 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.22% | 0.00% | 2,247,383 | 341,400 | 17.91% | 7,372,346 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.32% | 0.00% | 2,348,554 | 336,296 | 16.71% | 7,703,257 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.32% | 0.09% | 324,585 | 324,585 | 100.00% | 1,064,639 | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | 0.35% | 0.06% | 355,225 | 320,745 | 930.23% | 1,165,138 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.99% | 0.02% | 2,008,862 | 294,738 | 17.19% | 6,587,000 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.21% | 0.01% | 215,600 | 215,600 | 100.00% | 707,168 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.26% | 0.06% | 264,467 | 212,188 | 405.88% | 867,000 | Jun 30, 2024 |
As of Jun 30 2024, Fate Therapeutics's largest institutional buyer is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). The company purchased 1.37M stocks of FATE, valued at $11.66M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 5.28% | 0.00% | 5,338,689 | -2,697,980 | -33.57% | 17,510,900,000 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | - | - | - | -2,562,852 | -100.00% | - | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | - | - | - | -2,527,747 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -1,584,300 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.86% | 0.01% | 870,000 | -1,270,000 | -59.35% | 2,853,600 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.99% | 0.03% | 1,002,002 | -890,000 | -47.04% | 3,286,567 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -886,925 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | 0.10% | 0.00% | 102,096 | -863,335 | -89.42% | 334,875 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.25% | 0.00% | 250,793 | -478,864 | -65.63% | 822,601 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -460,000 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.49% | 2.06% | 497,360 | -423,116 | -45.97% | 1,631,341 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.68% | 0.02% | 1,694,217 | -305,605 | -15.28% | 5,557,032 | Jun 30, 2024 |
| UBS GROUP AG | 0.16% | 0.00% | 164,356 | -279,694 | -62.99% | 539,088 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.10% | 0.00% | 102,295 | -276,313 | -72.98% | 335,528 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -257,716 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.06% | - | 65,219 | -209,070 | -76.22% | 214,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.54% | 0.00% | 1,554,224 | -205,097 | -11.66% | 5,097,855 | Jun 30, 2024 |
| BARCLAYS PLC | 0.12% | 0.00% | 122,888 | -201,355 | -62.10% | 403,000 | Jun 30, 2024 |
| CAXTON ASSOCIATES LP | 0.17% | 0.02% | 172,863 | -117,324 | -40.43% | 566,991 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Fate Therapeutics's biggest institutional seller is STATE STREET CORP. The company sold -2.70M shares of FATE, valued at $17.51B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 0.54% | 0.00% | 548,544 | 548,544 | 100.00% | 1,799,224 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 0.34% | 0.03% | 345,575 | 345,575 | 100.00% | 1,133,486 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.32% | 0.09% | 324,585 | 324,585 | 100.00% | 1,064,639 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.21% | 0.01% | 215,600 | 215,600 | 100.00% | 707,168 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.19% | 0.00% | 188,460 | 188,460 | 100.00% | 618,149 | Jun 30, 2024 |
| SWISS NATIONAL BANK | 0.18% | 0.00% | 179,100 | 179,100 | 100.00% | 587,448,000 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.10% | 0.00% | 100,566 | 100,566 | 100.00% | 330,000 | Jun 30, 2024 |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 0.08% | 0.00% | 77,816 | 77,816 | 100.00% | 255,236 | Jun 30, 2024 |
| TOROSO INVESTMENTS, LLC | 0.07% | 0.00% | 71,955 | 71,955 | 100.00% | 236,012 | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | 0.06% | 0.03% | 58,365 | 58,365 | 100.00% | 191,437 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 53,859 | 53,859 | 100.00% | 176,658 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 51,744 | 51,744 | 100.00% | 169,579 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.04% | 0.00% | 36,675 | 36,675 | 100.00% | 120,294 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.03% | 0.02% | 28,652 | 28,652 | 100.00% | 93,979 | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.03% | 0.00% | 25,486 | 25,486 | 100.00% | 83,594 | Jun 30, 2024 |
| DRW SECURITIES, LLC | 0.02% | 0.00% | 21,550 | 21,550 | 100.00% | 70,684 | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0.02% | 0.00% | 19,999 | 19,999 | 100.00% | 66,000 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.02% | 0.01% | 19,065 | 19,065 | 100.00% | 62,533 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.02% | 0.00% | 17,053 | 17,053 | 100.00% | 55,934 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.01% | 0.00% | 11,565 | 11,565 | 100.00% | 37,933 | Jun 30, 2024 |
| LEO WEALTH, LLC | 0.01% | 0.00% | 10,439 | 10,439 | 100.00% | 34,240 | Jun 30, 2024 |
| AUSDAL FINANCIAL PARTNERS, INC. | 0.01% | 0.00% | 10,007 | 10,007 | 100.00% | 32,823 | Jun 30, 2024 |
| DOHENY ASSET MANAGEMENT /CA | 0.01% | 0.15% | 7,670 | 7,670 | 100.00% | 263,000 | Jun 30, 2024 |
| AMUNDI | 0.00% | - | 4,990 | 4,990 | 100.00% | 15,768 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 858 | 858 | 100.00% | 2,814 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | - | 102 | 102 | 100.00% | 335 | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | 0.00% | - | 100 | 100 | 100.00% | 326 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 35 | 35 | 100.00% | 115 | Jun 30, 2024 |
| - | - | 10 | 10 | 100.00% | 33 | Jun 30, 2024 | |
| INNEALTA CAPITAL, LLC | - | - | 9 | 9 | 100.00% | 30 | Jun 30, 2024 |
| MATHER GROUP, LLC. | - | - | 5 | 5 | 100.00% | 37 | Jun 30, 2024 |
Fate Therapeutics's largest new institutional shareholder by number of shares is RENAISSANCE TECHNOLOGIES LLC, purchased 548.54K shares, valued at $1.80M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | - | - | - | -2,562,852 | -100.00% | - | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | - | - | - | -2,527,747 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -1,584,300 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -886,925 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -460,000 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -257,716 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -58,835 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -47,200 | -100.00% | - | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | - | - | - | -43,399 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -41,767 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -39,800 | -100.00% | - | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| INCEPTIONR LLC | - | - | - | -23,343 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -22,039 | -100.00% | - | Jun 30, 2024 |
| AXQ CAPITAL, LP | - | - | - | -20,400 | -100.00% | - | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -19,375 | -100.00% | - | Jun 30, 2024 |
| EPIQ PARTNERS, LLC | - | - | - | -10,071 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -4,590 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,050 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -879 | -100.00% | - | Jun 30, 2024 |
| VERSANT CAPITAL MANAGEMENT, INC | - | - | - | -83 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -17 | -100.00% | - | Jun 30, 2024 |
Fate Therapeutics's largest sold out institutional shareholder by shares sold is SUVRETTA CAPITAL MANAGEMENT, LLC, sold -2.56M shares, valued at -, as of undefined.
Fate Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Vanguard Montgomery Funds | 1.40% | 333,530 | 353,936 | -1734.47% | Mar 31, 2024 |
| Ark ETF Trust | 1.39% | 11,151,443 | - | - | Jan 31, 2024 |
| HSBC FUNDS | 0.59% | 18,960 | - | - | Jan 31, 2024 |
| NEW ECONOMY FUND | 0.46% | 2,094,550 | - | - | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.45% | 1,099,314 | -1,151,535 | -51.16% | Jan 31, 2024 |
| Tema ETF Trust | 0.44% | 19,532 | 19,532 | - | Feb 29, 2024 |
| WANGER ADVISORS TRUST | 0.29% | 158,462 | - | - | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.26% | 543,958 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.21% | 39,694 | -75,443 | -65.52% | Mar 28, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.19% | 47,738 | - | - | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.19% | 635,972 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.19% | 931,034 | - | - | Mar 31, 2024 |
| EntrepreneurShares Series Trust | 0.17% | 45,738 | - | - | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.12% | 63,965 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.12% | 2,856,450 | -1,300,547 | -31.29% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.12% | 1,438,594 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.12% | 419,000 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.11% | 367,000 | - | - | Mar 31, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.09% | 43,399 | -63,919 | -59.56% | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.09% | 285,009 | - | - | Mar 31, 2024 |
| GROWTH FUND OF AMERICA | 0.09% | 2,174,249 | - | - | Feb 29, 2024 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.08% | 26,900 | - | - | Mar 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.08% | 47,660 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.08% | 1,690 | - | - | Dec 31, 2023 |
| BRUCE FUND INC | 0.07% | 143,000 | -57,000 | -28.50% | Dec 31, 2023 |
| Manager Directed Portfolios | 0.06% | 9,872 | - | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.05% | 24,080 | - | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.05% | 16,871 | - | - | Mar 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.05% | 3,353 | - | - | Sep 30, 2022 |
| SARATOGA ADVANTAGE TRUST | 0.05% | 2,841 | - | - | Feb 29, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.04% | 210,761 | - | - | Feb 29, 2024 |
| SMALLCAP WORLD FUND INC | 0.04% | 2,515,964 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.04% | 16,558 | - | - | Mar 31, 2024 |
| NEUBERGER BERMAN ADVISERS MANAGEMENT TRUST | 0.03% | 59,900 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.03% | 250,000 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.03% | 296,061 | - | - | Jan 31, 2024 |
| Voya EQUITY TRUST | 0.03% | 41,771 | - | - | Feb 29, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.03% | 214,900 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.03% | 222,810 | - | - | Jan 31, 2024 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.02% | 2,300 | - | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 149,766 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 36,150 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 12,699 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.02% | 54,460 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 198,900 | - | - | Mar 31, 2024 |
| PIONEER SERIES TRUST II | 0.02% | 207,563 | - | - | Feb 29, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.02% | 15,094 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.02% | 113,561 | 42,546 | 59.91% | Aug 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.01% | 40,000 | - | - | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 439,137 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 566,697 | 38,651 | 7.32% | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 18,216 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.01% | 11,277 | - | - | Jan 31, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.01% | 1,293 | - | - | Dec 29, 2023 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.01% | 106,210 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,380 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.01% | 51,000 | -2,200 | -4.14% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,290,254 | -640,066 | -12.98% | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.01% | 7,991 | - | - | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 29,266 | - | - | Feb 29, 2024 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.01% | 296,684 | - | - | Jan 31, 2024 |
| AdvisorShares Trust | 0.01% | 33,153 | - | - | Mar 28, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 44,303 | 4,406 | 11.04% | Mar 31, 2020 |
| FORUM FUNDS | 0.01% | 15,830 | - | - | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.01% | 121,800 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.01% | 925,105 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 70,328 | 438 | 0.63% | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.01% | 68,988 | 45,088 | 188.65% | Mar 31, 2023 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.00% | 15,149 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 61,308 | - | - | Feb 29, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 252,637 | -123,262 | -32.79% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 87,747 | -1,014 | -1.14% | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 39,990 | - | - | Mar 31, 2024 |
| Collaborative Investment Series Trust | 0.00% | 692 | - | - | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 26,742 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 866,938 | 152,271 | 21.31% | Feb 29, 2024 |
| Jacob Funds Inc. | 0.00% | 902 | - | - | Feb 29, 2024 |
| North Square Investments Trust | 0.00% | 37,750 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 1,990 | -163 | -7.57% | Apr 30, 2021 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 117,138 | -1,851 | -1.56% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 8,047 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 74,978 | 12,016 | 19.08% | Feb 29, 2024 |
| ProFunds | 0.00% | 37,702 | 36,989 | 5187.80% | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.00% | 7,364 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 12,294 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 13,009 | 5,864 | 82.07% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 8,358 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.00% | 1,712 | 370 | 27.57% | Sep 30, 2020 |
| JANUS INVESTMENT FUND | 0.00% | 943,765 | - | - | Dec 31, 2023 |
| FIDELITY SECURITIES FUND | 0.00% | 269,633 | - | - | Jan 31, 2024 |
| UBS FUNDS | 0.00% | 13,652 | - | - | Mar 31, 2024 |
| CARILLON SERIES TRUST | 0.00% | 156,200 | - | - | Mar 31, 2024 |
| Segall Bryant & Hamill Trust | 0.00% | 50,943 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 315,500 | 23,316 | 7.98% | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 859 | - | - | Feb 29, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 32,770 | 25,676 | 361.94% | Mar 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 1,378 | - | - | Sep 30, 2023 |
| VANGUARD WHITEHALL FUNDS | 0.00% | 169,270 | - | - | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 35,418 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 90,000 | - | - | Feb 29, 2024 |
Fate Therapeutics's largest mutual fund holder by % of total assets is "Vanguard Montgomery Funds", owning 333.53K shares, compromising 1.40% of its total assets.
Fate Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 181 | 7.74% |
| 31 Mar, 24 | 168 | 7.01% |
| 31 Dec, 23 | 157 | -5.99% |
| 30 Sep, 23 | 167 | -11.64% |
| 30 Jun, 23 | 189 | 2.72% |
| 31 Mar, 23 | 184 | -20.35% |
| 31 Dec, 22 | 231 | -2.94% |
| 30 Sep, 22 | 238 | 3.48% |
| 30 Jun, 22 | 230 | -9.80% |
| 31 Mar, 22 | 255 | 0.39% |
| 31 Dec, 21 | 254 | -7.30% |
| 30 Sep, 21 | 274 | -2.49% |
| 30 Jun, 21 | 281 | 4.85% |
| 31 Mar, 21 | 268 | 1.90% |
| 31 Dec, 20 | 263 | 20.09% |
| 30 Sep, 20 | 219 | 3.79% |
| 30 Jun, 20 | 211 | 26.35% |
| 31 Mar, 20 | 167 | 7.05% |
| 31 Dec, 19 | 156 | 2.63% |
| 30 Sep, 19 | 152 | 9.35% |
| 30 Jun, 19 | 139 | 9.45% |
| 31 Mar, 19 | 127 | - |
| 31 Dec, 18 | 127 | 3.25% |
| 30 Sep, 18 | 123 | 13.89% |
| 30 Jun, 18 | 108 | 17.39% |
| 31 Mar, 18 | 92 | 17.95% |
| 31 Dec, 17 | 78 | 9.86% |
| 30 Sep, 17 | 71 | 22.41% |
| 30 Jun, 17 | 58 | 13.73% |
| 31 Mar, 17 | 51 | 45.71% |
| 31 Dec, 16 | 35 | -10.26% |
| 30 Sep, 16 | 39 | 5.41% |
| 30 Jun, 16 | 37 | -15.91% |
| 31 Mar, 16 | 44 | -15.38% |
| 31 Dec, 15 | 52 | 20.93% |
| 30 Sep, 15 | 43 | 13.16% |
| 30 Jun, 15 | 38 | 52.00% |
| 31 Mar, 15 | 25 | 8.70% |
| 31 Dec, 14 | 23 | 4.55% |
| 30 Sep, 14 | 22 | - |
| 30 Jun, 14 | 22 | 4.76% |
| 31 Mar, 14 | 21 | 40.00% |
| 31 Dec, 13 | 15 | - |
As of 30 Jun 24, 181 institutions are holding Fate Therapeutics's shares, representing an increase of 7.74% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 122,176,866 | -0.69% |
| 31 Mar, 24 | 123,027,798 | 29.12% |
| 31 Dec, 23 | 95,280,535 | -0.40% |
| 30 Sep, 23 | 95,660,318 | -12.34% |
| 30 Jun, 23 | 109,126,684 | -3.03% |
| 31 Mar, 23 | 112,540,691 | 6.54% |
| 31 Dec, 22 | 105,628,266 | -2.01% |
| 30 Sep, 22 | 107,789,705 | -1.57% |
| 30 Jun, 22 | 109,504,745 | 8.25% |
| 31 Mar, 22 | 101,158,264 | 4.42% |
| 31 Dec, 21 | 96,875,426 | 1.24% |
| 30 Sep, 21 | 95,692,433 | 1.37% |
| 30 Jun, 21 | 94,396,129 | 0.74% |
| 31 Mar, 21 | 93,705,097 | 7.26% |
| 31 Dec, 20 | 87,362,855 | -0.46% |
| 30 Sep, 20 | 87,767,131 | 2.15% |
| 30 Jun, 20 | 85,918,479 | 13.62% |
| 31 Mar, 20 | 75,615,839 | 4.72% |
| 31 Dec, 19 | 72,206,268 | -2.14% |
| 30 Sep, 19 | 73,785,101 | 16.82% |
| 30 Jun, 19 | 63,158,930 | 3.87% |
| 31 Mar, 19 | 60,804,539 | 2.32% |
| 31 Dec, 18 | 59,428,218 | 8.38% |
| 30 Sep, 18 | 54,835,180 | 27.29% |
| 30 Jun, 18 | 43,078,854 | 9.30% |
| 31 Mar, 18 | 39,414,357 | 11.51% |
| 31 Dec, 17 | 35,346,139 | 39.10% |
| 30 Sep, 17 | 25,411,100 | -4.51% |
| 30 Jun, 17 | 26,612,483 | 6.32% |
| 31 Mar, 17 | 25,029,697 | 8.21% |
| 31 Dec, 16 | 23,130,204 | 18.72% |
| 30 Sep, 16 | 19,482,835 | 38.45% |
| 30 Jun, 16 | 14,071,764 | -10.82% |
| 31 Mar, 16 | 15,779,537 | -15.23% |
| 31 Dec, 15 | 18,614,200 | 1.44% |
| 30 Sep, 15 | 18,349,823 | 1.84% |
| 30 Jun, 15 | 18,018,724 | 69.85% |
| 31 Mar, 15 | 10,608,825 | 3.25% |
| 31 Dec, 14 | 10,275,348 | 0.05% |
| 30 Sep, 14 | 10,270,565 | 4.23% |
| 30 Jun, 14 | 9,853,480 | 3.03% |
| 31 Mar, 14 | 9,563,611 | 143.40% |
| 31 Dec, 13 | 3,929,193 | - |
Fate Therapeutics (FATE) has 122.18M shares outstanding as of 30 Jun 24, down -0.69% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 120.84% | 0.82% |
| 31 Mar, 24 | 121.68% | 1.30% |
| 31 Dec, 23 | 96.82% | 1.03% |
| 30 Sep, 23 | 97.05% | 0.79% |
| 30 Jun, 23 | 110.90% | 0.84% |
| 31 Mar, 23 | 114.77% | 0.97% |
| 31 Dec, 22 | 108.65% | 0.88% |
| 30 Sep, 22 | 111.10% | 0.87% |
| 30 Jun, 22 | 113.24% | 1.03% |
| 31 Mar, 22 | 105.00% | 1.03% |
| 31 Dec, 21 | 101.13% | 1.01% |
| 30 Sep, 21 | 100.30% | 1.00% |
| 30 Jun, 21 | 100.07% | 0.99% |
| 31 Mar, 21 | 100.29% | 0.89% |
| 31 Dec, 20 | 106.04% | 1.04% |
| 30 Sep, 20 | 101.01% | 0.86% |
| 30 Jun, 20 | 108.34% | 1.09% |
| 31 Mar, 20 | 99.64% | 0.89% |
| 31 Dec, 19 | 105.89% | 0.87% |
| 30 Sep, 19 | 110.24% | 1.18% |
| 30 Jun, 19 | 96.85% | 1.10% |
| 31 Mar, 19 | 93.66% | 1.11% |
| 31 Dec, 18 | 92.00% | 0.90% |
| 30 Sep, 18 | 101.20% | 1.54% |
| 30 Jun, 18 | 81.08% | 1.45% |
| 31 Mar, 18 | 74.70% | 1.14% |
| 31 Dec, 17 | 80.91% | 2.15% |
| 30 Sep, 17 | 61.34% | 1.48% |
| 30 Jun, 17 | 64.27% | 1.76% |
| 31 Mar, 17 | 60.48% | 1.14% |
| 31 Dec, 16 | 72.84% | 1.98% |
| 30 Sep, 16 | 60.71% | 2.56% |
| 30 Jun, 16 | 48.74% | 1.62% |
| 31 Mar, 16 | 54.83% | 1.30% |
| 31 Dec, 15 | 64.89% | 1.58% |
| 30 Sep, 15 | 64.05% | 1.13% |
| 30 Jun, 15 | 75.33% | 2.83% |
| 31 Mar, 15 | 51.61% | 2.04% |
| 31 Dec, 14 | 50.24% | 2.00% |
| 30 Sep, 14 | 50.13% | 2.16% |
| 30 Jun, 14 | 48.14% | 2.18% |
| 31 Mar, 14 | 47.00% | 11.84% |
| 31 Dec, 13 | 19.93% | - |
As of 30 Jun 24, Fate Therapeutics is held by 120.84% institutional shareholders, representing a 0.82% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 95 | 6.74% |
| 31 Mar, 24 | 89 | 32.84% |
| 31 Dec, 23 | 67 | -16.25% |
| 30 Sep, 23 | 80 | -14.89% |
| 30 Jun, 23 | 94 | 2.17% |
| 31 Mar, 23 | 92 | -31.34% |
| 31 Dec, 22 | 134 | 15.52% |
| 30 Sep, 22 | 116 | -0.85% |
| 30 Jun, 22 | 117 | -12.03% |
| 31 Mar, 22 | 133 | - |
| 31 Dec, 21 | 133 | -6.99% |
| 30 Sep, 21 | 143 | -5.92% |
| 30 Jun, 21 | 152 | 7.80% |
| 31 Mar, 21 | 141 | - |
| 31 Dec, 20 | 141 | 18.49% |
| 30 Sep, 20 | 119 | -6.30% |
| 30 Jun, 20 | 127 | 54.88% |
| 31 Mar, 20 | 82 | -7.87% |
| 31 Dec, 19 | 89 | 5.95% |
| 30 Sep, 19 | 84 | 35.48% |
| 30 Jun, 19 | 62 | 6.90% |
| 31 Mar, 19 | 58 | -25.64% |
| 31 Dec, 18 | 78 | 5.41% |
| 30 Sep, 18 | 74 | 5.71% |
| 30 Jun, 18 | 70 | 18.64% |
| 31 Mar, 18 | 59 | 25.53% |
| 31 Dec, 17 | 47 | 34.29% |
| 30 Sep, 17 | 35 | -5.41% |
| 30 Jun, 17 | 37 | 8.82% |
| 31 Mar, 17 | 34 | 100.00% |
| 31 Dec, 16 | 17 | -10.53% |
| 30 Sep, 16 | 19 | 72.73% |
| 30 Jun, 16 | 11 | -50.00% |
| 31 Mar, 16 | 22 | -31.25% |
| 31 Dec, 15 | 32 | 28.00% |
| 30 Sep, 15 | 25 | -24.24% |
| 30 Jun, 15 | 33 | 135.71% |
| 31 Mar, 15 | 14 | - |
| 31 Dec, 14 | 14 | - |
| 30 Sep, 14 | 14 | - |
| 30 Jun, 14 | 14 | 16.67% |
| 31 Mar, 14 | 12 | -20.00% |
| 31 Dec, 13 | 15 | - |
95 institutional shareholders have increased their position in FATE stock as of 30 Jun 24 compared to 89 in the previous quarter (a 6.74% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 48 | -5.88% |
| 31 Mar, 24 | 51 | -15.00% |
| 31 Dec, 23 | 60 | 20.00% |
| 30 Sep, 23 | 50 | -10.71% |
| 30 Jun, 23 | 56 | -1.75% |
| 31 Mar, 23 | 57 | - |
| 31 Dec, 22 | 57 | -25.97% |
| 30 Sep, 22 | 77 | 13.24% |
| 30 Jun, 22 | 68 | -6.85% |
| 31 Mar, 22 | 73 | 4.29% |
| 31 Dec, 21 | 70 | -10.26% |
| 30 Sep, 21 | 78 | 4.00% |
| 30 Jun, 21 | 75 | -13.79% |
| 31 Mar, 21 | 87 | -8.42% |
| 31 Dec, 20 | 95 | 50.79% |
| 30 Sep, 20 | 63 | 18.87% |
| 30 Jun, 20 | 53 | -7.02% |
| 31 Mar, 20 | 57 | 54.05% |
| 31 Dec, 19 | 37 | -7.50% |
| 30 Sep, 19 | 40 | -11.11% |
| 30 Jun, 19 | 45 | 2.27% |
| 31 Mar, 19 | 44 | 37.50% |
| 31 Dec, 18 | 32 | 23.08% |
| 30 Sep, 18 | 26 | 30.00% |
| 30 Jun, 18 | 20 | - |
| 31 Mar, 18 | 20 | 11.11% |
| 31 Dec, 17 | 18 | -14.29% |
| 30 Sep, 17 | 21 | 90.91% |
| 30 Jun, 17 | 11 | 57.14% |
| 31 Mar, 17 | 7 | -22.22% |
| 31 Dec, 16 | 9 | -25.00% |
| 30 Sep, 16 | 12 | -7.69% |
| 30 Jun, 16 | 13 | 8.33% |
| 31 Mar, 16 | 12 | 50.00% |
| 31 Dec, 15 | 8 | -33.33% |
| 30 Sep, 15 | 12 | 1100.00% |
| 30 Jun, 15 | 1 | -83.33% |
| 31 Mar, 15 | 6 | 50.00% |
| 31 Dec, 14 | 4 | - |
| 30 Sep, 14 | 4 | - |
| 30 Jun, 14 | 4 | -33.33% |
| 31 Mar, 14 | 6 | - |
| 31 Dec, 13 | - | - |
48 institutional shareholders have reduced their position in FATE stock as of 30 Jun 24 compared to 51 in the previous quarter (a -5.88% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 181 | 7.74% | 122,176,866 | -0.69% | 120.84% | 0.82% | 95 | 6.74% | 48 | -5.88% |
| 31 Mar, 24 | 168 | 7.01% | 123,027,798 | 29.12% | 121.68% | 1.30% | 89 | 32.84% | 51 | -15.00% |
| 31 Dec, 23 | 157 | -5.99% | 95,280,535 | -0.40% | 96.82% | 1.03% | 67 | -16.25% | 60 | 20.00% |
| 30 Sep, 23 | 167 | -11.64% | 95,660,318 | -12.34% | 97.05% | 0.79% | 80 | -14.89% | 50 | -10.71% |
| 30 Jun, 23 | 189 | 2.72% | 109,126,684 | -3.03% | 110.90% | 0.84% | 94 | 2.17% | 56 | -1.75% |
| 31 Mar, 23 | 184 | -20.35% | 112,540,691 | 6.54% | 114.77% | 0.97% | 92 | -31.34% | 57 | - |
| 31 Dec, 22 | 231 | -2.94% | 105,628,266 | -2.01% | 108.65% | 0.88% | 134 | 15.52% | 57 | -25.97% |
| 30 Sep, 22 | 238 | 3.48% | 107,789,705 | -1.57% | 111.10% | 0.87% | 116 | -0.85% | 77 | 13.24% |
| 30 Jun, 22 | 230 | -9.80% | 109,504,745 | 8.25% | 113.24% | 1.03% | 117 | -12.03% | 68 | -6.85% |
| 31 Mar, 22 | 255 | 0.39% | 101,158,264 | 4.42% | 105.00% | 1.03% | 133 | - | 73 | 4.29% |
| 31 Dec, 21 | 254 | -7.30% | 96,875,426 | 1.24% | 101.13% | 1.01% | 133 | -6.99% | 70 | -10.26% |
| 30 Sep, 21 | 274 | -2.49% | 95,692,433 | 1.37% | 100.30% | 1.00% | 143 | -5.92% | 78 | 4.00% |
| 30 Jun, 21 | 281 | 4.85% | 94,396,129 | 0.74% | 100.07% | 0.99% | 152 | 7.80% | 75 | -13.79% |
| 31 Mar, 21 | 268 | 1.90% | 93,705,097 | 7.26% | 100.29% | 0.89% | 141 | - | 87 | -8.42% |
| 31 Dec, 20 | 263 | 20.09% | 87,362,855 | -0.46% | 106.04% | 1.04% | 141 | 18.49% | 95 | 50.79% |
| 30 Sep, 20 | 219 | 3.79% | 87,767,131 | 2.15% | 101.01% | 0.86% | 119 | -6.30% | 63 | 18.87% |
| 30 Jun, 20 | 211 | 26.35% | 85,918,479 | 13.62% | 108.34% | 1.09% | 127 | 54.88% | 53 | -7.02% |
| 31 Mar, 20 | 167 | 7.05% | 75,615,839 | 4.72% | 99.64% | 0.89% | 82 | -7.87% | 57 | 54.05% |
| 31 Dec, 19 | 156 | 2.63% | 72,206,268 | -2.14% | 105.89% | 0.87% | 89 | 5.95% | 37 | -7.50% |
| 30 Sep, 19 | 152 | 9.35% | 73,785,101 | 16.82% | 110.24% | 1.18% | 84 | 35.48% | 40 | -11.11% |
| 30 Jun, 19 | 139 | 9.45% | 63,158,930 | 3.87% | 96.85% | 1.10% | 62 | 6.90% | 45 | 2.27% |
| 31 Mar, 19 | 127 | - | 60,804,539 | 2.32% | 93.66% | 1.11% | 58 | -25.64% | 44 | 37.50% |
| 31 Dec, 18 | 127 | 3.25% | 59,428,218 | 8.38% | 92.00% | 0.90% | 78 | 5.41% | 32 | 23.08% |
| 30 Sep, 18 | 123 | 13.89% | 54,835,180 | 27.29% | 101.20% | 1.54% | 74 | 5.71% | 26 | 30.00% |
| 30 Jun, 18 | 108 | 17.39% | 43,078,854 | 9.30% | 81.08% | 1.45% | 70 | 18.64% | 20 | - |
| 31 Mar, 18 | 92 | 17.95% | 39,414,357 | 11.51% | 74.70% | 1.14% | 59 | 25.53% | 20 | 11.11% |
| 31 Dec, 17 | 78 | 9.86% | 35,346,139 | 39.10% | 80.91% | 2.15% | 47 | 34.29% | 18 | -14.29% |
| 30 Sep, 17 | 71 | 22.41% | 25,411,100 | -4.51% | 61.34% | 1.48% | 35 | -5.41% | 21 | 90.91% |
| 30 Jun, 17 | 58 | 13.73% | 26,612,483 | 6.32% | 64.27% | 1.76% | 37 | 8.82% | 11 | 57.14% |
| 31 Mar, 17 | 51 | 45.71% | 25,029,697 | 8.21% | 60.48% | 1.14% | 34 | 100.00% | 7 | -22.22% |
| 31 Dec, 16 | 35 | -10.26% | 23,130,204 | 18.72% | 72.84% | 1.98% | 17 | -10.53% | 9 | -25.00% |
| 30 Sep, 16 | 39 | 5.41% | 19,482,835 | 38.45% | 60.71% | 2.56% | 19 | 72.73% | 12 | -7.69% |
| 30 Jun, 16 | 37 | -15.91% | 14,071,764 | -10.82% | 48.74% | 1.62% | 11 | -50.00% | 13 | 8.33% |
| 31 Mar, 16 | 44 | -15.38% | 15,779,537 | -15.23% | 54.83% | 1.30% | 22 | -31.25% | 12 | 50.00% |
| 31 Dec, 15 | 52 | 20.93% | 18,614,200 | 1.44% | 64.89% | 1.58% | 32 | 28.00% | 8 | -33.33% |
| 30 Sep, 15 | 43 | 13.16% | 18,349,823 | 1.84% | 64.05% | 1.13% | 25 | -24.24% | 12 | 1100.00% |
| 30 Jun, 15 | 38 | 52.00% | 18,018,724 | 69.85% | 75.33% | 2.83% | 33 | 135.71% | 1 | -83.33% |
| 31 Mar, 15 | 25 | 8.70% | 10,608,825 | 3.25% | 51.61% | 2.04% | 14 | - | 6 | 50.00% |
| 31 Dec, 14 | 23 | 4.55% | 10,275,348 | 0.05% | 50.24% | 2.00% | 14 | - | 4 | - |
| 30 Sep, 14 | 22 | - | 10,270,565 | 4.23% | 50.13% | 2.16% | 14 | - | 4 | - |
| 30 Jun, 14 | 22 | 4.76% | 9,853,480 | 3.03% | 48.14% | 2.18% | 14 | 16.67% | 4 | -33.33% |
| 31 Mar, 14 | 21 | 40.00% | 9,563,611 | 143.40% | 47.00% | 11.84% | 12 | -20.00% | 6 | - |
| 31 Dec, 13 | 15 | - | 3,929,193 | - | 19.93% | - | 15 | - | - | - |
Fate Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Fate Therapeutics's stock was made by Xu Yuan on Aug 07 2024, selling 633 shares at $4.23 per share (valued at $2.68K).
Fate Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | 1 | 300.00% |
| Q2 2024 | 9 | - | - |
| Q1 2024 | 5 | 7 | 71.43% |
| Q4 2023 | 2 | 3 | 66.67% |
| Q3 2023 | - | 4 | - |
| Q2 2023 | 18 | 9 | 200.00% |
| Q1 2023 | 12 | 6 | 200.00% |
| Q3 2022 | 3 | 10 | 30.00% |
| Q2 2022 | 24 | 15 | 160.00% |
| Q1 2022 | 17 | 38 | 44.74% |
| Q4 2021 | 16 | 28 | 57.14% |
| Q3 2021 | 12 | 34 | 35.29% |
| Q2 2021 | 29 | 26 | 111.54% |
| Q1 2021 | 17 | 73 | 23.29% |
| Q4 2020 | 11 | 38 | 28.95% |
| Q3 2020 | 4 | 9 | 44.44% |
| Q2 2020 | 11 | - | - |
| Q1 2020 | 12 | 8 | 150.00% |
| Q4 2019 | 2 | 11 | 18.18% |
| Q3 2019 | 3 | 42 | 7.14% |
3 total buy trades, and 1 total sell trades (buy/sell ratio of 3.00%) were made by Fate Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | 1 | 2 | 50.00% |
| Q3 2023 | - | 4 | - |
| Q2 2023 | 3 | 4 | 75.00% |
| Q1 2023 | 2 | 6 | 33.33% |
| Q3 2022 | - | 6 | - |
| Q2 2022 | - | 11 | - |
| Q1 2022 | - | 30 | - |
| Q4 2021 | - | 20 | - |
| Q3 2021 | - | 23 | - |
| Q2 2021 | - | 17 | - |
| Q1 2021 | 2 | 62 | 3.23% |
| Q4 2020 | - | 27 | - |
| Q3 2020 | - | 7 | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | - | 4 | - |
| Q4 2019 | - | 8 | - |
| Q3 2019 | 1 | 40 | 2.50% |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Fate Therapeutics's stocks.
Fate Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| SANA | Sana Biotechnology, Inc. |
| CRSP | CRISPR Therapeutics AG |
| ATRA | Atara Biotherapeutics, Inc. |
| RCUS | Arcus Biosciences, Inc. |
| BPMC | Blueprint Medicines Corporation |
| IPSC | Century Therapeutics, Inc. |
| NTLA | Intellia Therapeutics, Inc. |
| EDIT | Editas Medicine, Inc. |
| PRME | Prime Medicine, Inc. |
| VERV | Verve Therapeutics, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| CRBU | Caribou Biosciences, Inc. |
| BEAM | Beam Therapeutics Inc. |
| LIFE | aTyr Pharma, Inc. |
FATE Ownership FAQ
Who Owns Fate Therapeutics?
Fate Therapeutics is owned by institutional shareholders (120.84%), insiders (2.17%), and public (-23.02%). The largest institutional shareholder of Fate Therapeutics is REDMILE GROUP, LLC (13.03% of total shares) and the top mutual fund owner is Vanguard Montgomery Funds (1.40% of total shares).
Who are the major institutional shareholders of Fate Therapeutics?
Fate Therapeutics's major institutional shareholders are REDMILE GROUP, LLC, VANGUARD GROUP INC, BLACKROCK INC., BOXER CAPITAL, LLC, and DEEP TRACK CAPITAL, LP. The top five shareholders own together 47.12% of the company's share outstanding.
How many Fate Therapeutics shareholders are there?
As of Jun 2024, there are 181 institutional shareholders of Fate Therapeutics.
What percentage of Fate Therapeutics is owned by REDMILE GROUP, LLC?
REDMILE GROUP, LLC owns 13.17M shares of Fate Therapeutics, representing 13.03% of the company's total shares outstanding, valued at $43.19M (as of Jun 2024).
What percentage of Fate Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 10.57M shares of Fate Therapeutics (FATE), compromising 10.45% of the company, valued at $34.67M.
What percentage of Fate Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Fate Therapeutics. The company owns 10.12M of the company's shares outstanding (worth $33.18M).